+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radioembolization Therapy Market by Component, Treatment Category, Tumor Type, Application Procedure, End-User - Global Forecast to 2030- Product Image
Radioembolization Therapy Market by Component, Treatment Category, Tumor Type, Application Procedure, End-User - Global Forecast to 2030- Product Image
Sale

Radioembolization Therapy Market by Component, Treatment Category, Tumor Type, Application Procedure, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 188 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055349
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The radioembolization therapy market is undergoing rapid transformation as new clinical protocols, advanced technologies, and supply chain realignments shape its trajectory in interventional oncology. Senior executives face evolving opportunities and pressures in this environment, demanding a nuanced view into strategic drivers, regulatory responses, and regional dynamics.

Market Snapshot: Radioembolization Therapy Market Growth and Opportunities

The global radioembolization therapy market grew from USD 1.09 billion in 2024 to USD 1.15 billion in 2025, and is poised for continued expansion at a CAGR of 5.90%, reaching USD 1.54 billion by 2030. This trajectory reflects the sector’s steady adoption in advanced liver cancer treatment, underpinned by technological advancements and an increased focus on minimally invasive procedures. Healthcare systems across leading economies are realigning infrastructure, procurement strategies, and clinical guidelines to embed these innovations as standard-of-care, while navigating supply-side complexities and reimbursement reforms.

Scope & Segmentation of the Radioembolization Therapy Market

This report offers structured, actionable insight across the following segments and regions—each reflecting key influences on product development, clinical protocols, and market access.

  • Component: Catheters, Nuclear Medicine Equipment, Radioactive Microspheres, and X-Ray Equipment—analyzing their respective roles in procedural precision and treatment efficacy.
  • Treatment Category: Both Curative and Palliative applications—tracing the shift towards tailored, patient-specific approaches throughout the care continuum.
  • Tumor Type: Metastatic Liver Cancer and Primary Liver Cancer—with distinct procedural strategies and outcome priorities for each tumor profile.
  • Application Procedure: Includes Liver Tumour, Lobar Therapy, and Segmental Therapy, highlighting different complexity levels and technology needs.
  • End-User: Ambulatory Surgical Centers, Cancer Research Institutes, and Hospitals—each driving adoption through operational workflows and institutional priorities.
  • Regions:
    • Americas: Including United States (California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina.
    • Europe, Middle East & Africa: United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland.
    • Asia-Pacific: China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan.
  • Key Companies: Bayer AG, Becton Dickinson & Company, Boston Scientific Corporation, Cook Medical, Elekta AB, Fortis Healthcare Limited, Hamilton Health Sciences, Mayo Clinic Health System, Merit Medical Systems, Inc., Nordion Inc., Northwestern Memorial HealthCare, Radiological Society of North America, Inc., Siemens AG, Sirtex Medical Pty Ltd, Stryker Corporation, Terumo Corporation, United HealthCare Services, Inc.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Integration of next-generation catheter systems and advanced imaging is elevating treatment precision while potentially reducing procedure times and adverse event risk.
  • Personalized dosimetry and hybrid imaging protocols support a trend toward individualized therapy, enhancing local tumor control and broadening clinical eligibility.
  • Expanding procedural volumes have led healthcare organizations to recalibrate procurement and workforce training, highlighting the importance of interoperability and inclusive certification programs.
  • Emerging collaborations between technology providers, hospitals, and payers are streamlining reimbursement strategies, aiming to align procedural costs with evolving clinical value.
  • Segmented end-user adoption reveals that ambulatory centers emphasize efficiency, research institutes focus on clinical protocol advancement, and hospitals manage complex, multidisciplinary patient needs.
  • Regional differences in regulatory frameworks, investment incentives, and healthcare infrastructure influence adoption velocity and shape localized strategies for market entry.

2025 Tariff Impact on the Radioembolization Supply Chain

New tariffs affecting imported nuclear medicine equipment, catheter systems, and radioactive microspheres have increased operational costs and extended lead times, particularly in the United States. These tariffs prompt organizations to consider domestic manufacturing and strategic sourcing to maintain supply chain continuity. Dialogues with payers on reimbursement adjustments are intensifying, using economic data to justify higher procedural rates where applicable.

Methodology & Data Sources

This research is grounded in primary interviews with clinicians, procurement leaders, and regulators, as well as surveys of clinical practice patterns and procurement behaviors. Secondary analysis includes peer-reviewed studies, manufacturer disclosures, and healthcare utilization data, all validated by an expert advisory board.

Why This Report Matters

  • Enables strategic investment planning by presenting segmentation, technology, and regional trends critical to growth.
  • Informs procurement decisions and risk mitigation by analyzing supply chain vulnerabilities and tariff responses.
  • Supports adoption initiatives and clinical integration through evidence-based insights and actionable recommendations.

Conclusion

This report provides actionable intelligence to help organizations navigate the evolving radioembolization therapy market. Stakeholders can utilize these insights to inform decision-making, manage risk, and pursue new growth avenues in minimally invasive cancer care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Radioembolization Therapy Market, by Component
8.1. Introduction
8.2. Catheters
8.3. Nuclear Medicine Equipment
8.4. Radioactive Microspheres
8.5. X-Ray Equipment
9. Radioembolization Therapy Market, by Treatment Category
9.1. Introduction
9.2. Curative
9.3. Palliative
10. Radioembolization Therapy Market, by Tumor Type
10.1. Introduction
10.2. Metastatic Liver Cancer
10.3. Primary Liver Cancer
11. Radioembolization Therapy Market, by Application Procedure
11.1. Introduction
11.2. Liver Tumour
11.3. Lobar Therapy
11.4. Segmental Therapy
12. Radioembolization Therapy Market, by End-User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Cancer Research Institutes
12.4. Hospitals
13. Americas Radioembolization Therapy Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Radioembolization Therapy Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Radioembolization Therapy Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Bayer AG
16.3.2. Becton Dickinson & Company
16.3.3. Boston Scientific Corporation
16.3.4. Cook Medical
16.3.5. Elekta AB
16.3.6. Fortis Healthcare Limited
16.3.7. Hamilton Health Sciences
16.3.8. Mayo Clinic Health System
16.3.9. Merit Medical Systems, Inc.
16.3.10. Nordion Inc.
16.3.11. Northwestern Memorial HealthCare.
16.3.12. Radiological Society of North America, Inc.
16.3.13. Siemens AG
16.3.14. Sirtex Medical Pty Ltd
16.3.15. Stryker Corporation
16.3.16. Terumo Corporation
16.3.17. United HealthCare Services, Inc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RADIOEMBOLIZATION THERAPY MARKET MULTI-CURRENCY
FIGURE 2. RADIOEMBOLIZATION THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. RADIOEMBOLIZATION THERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. RADIOEMBOLIZATION THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. RADIOEMBOLIZATION THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RADIOEMBOLIZATION THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY NUCLEAR MEDICINE EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY RADIOACTIVE MICROSPHERES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY X-RAY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CURATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY PALLIATIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY METASTATIC LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY PRIMARY LIVER CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY LIVER TUMOUR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY LOBAR THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY SEGMENTAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 38. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 39. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 41. CANADA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 43. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 44. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 46. MEXICO RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 64. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 69. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 70. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 71. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 72. GERMANY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 74. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 75. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 76. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 77. FRANCE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 79. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 84. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 85. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 86. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 87. ITALY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 89. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 90. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 91. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 92. SPAIN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 99. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 104. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 109. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 110. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 112. DENMARK RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 114. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 119. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 120. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 121. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 122. QATAR RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 124. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 125. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 127. FINLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 139. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 140. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 142. EGYPT RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 144. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 145. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 146. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 147. TURKEY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 149. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 154. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 155. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 156. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 157. NORWAY RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 159. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 160. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 161. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 162. POLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SWITZERLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 174. CHINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 175. CHINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 176. CHINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 177. CHINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 178. CHINA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. INDIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 180. INDIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 181. INDIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 182. INDIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 183. INDIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. JAPAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 185. JAPAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 186. JAPAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 187. JAPAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 188. JAPAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. AUSTRALIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 190. AUSTRALIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 194. SOUTH KOREA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 195. SOUTH KOREA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. INDONESIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 200. INDONESIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. THAILAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 205. THAILAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 206. THAILAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 207. THAILAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 208. THAILAND RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. PHILIPPINES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 210. PHILIPPINES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. SINGAPORE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 220. SINGAPORE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 224. VIETNAM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 225. VIETNAM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. TAIWAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 230. TAIWAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TREATMENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY TUMOR TYPE, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY APPLICATION PROCEDURE, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN RADIOEMBOLIZATION THERAPY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. RADIOEMBOLIZATION THERAPY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 235. RADIOEMBOLIZATION THERAPY MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Radioembolization Therapy market report include:
  • Bayer AG
  • Becton Dickinson & Company
  • Boston Scientific Corporation
  • Cook Medical
  • Elekta AB
  • Fortis Healthcare Limited
  • Hamilton Health Sciences
  • Mayo Clinic Health System
  • Merit Medical Systems, Inc.
  • Nordion Inc.
  • Northwestern Memorial HealthCare.
  • Radiological Society of North America, Inc.
  • Siemens AG
  • Sirtex Medical Pty Ltd
  • Stryker Corporation
  • Terumo Corporation
  • United HealthCare Services, Inc

Table Information

Report AttributeDetails
No. of Pages188
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.15 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.54 Billion
Compound Annual Growth Rate5.9%
Regions CoveredGlobal
No. of Companies Mentioned18

Related Topics

Related Reports

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Applications (Liver Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Applications (Liver Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 210 Pages
  • Global
From
Carcinoid Tumor Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034) - Product Image

Carcinoid Tumor Market Growth Analysis Report - Market Size, Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Wilms Tumor Market - Product Image

Wilms Tumor Market

  • Report
  • 250 Pages
  • Global
From
Desmoid Tumors - Global Strategic Business Report - Product Image

Desmoid Tumors - Global Strategic Business Report

  • Report
  • 286 Pages
  • Global
From
Tumor Microenvironment Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Tumor Microenvironment Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.